Skip to Content

Sufentanil Injection

Last Updated: August 12, 2018
Status: Current

Products Affected - Description
    • Sufenta solution for injection, Akorn, 50 mcg/mL, 1 mL ampule, 10 count, NDC 17478-0050-01
    • Sufenta solution for injection, Akorn, 50 mcg/mL, 2 mL ampule, 10 count, NDC 17478-0050-02
    • Sufenta solution for injection, Akorn, 50 mcg/mL, 5 mL ampule, 10 count, NDC 17478-0050-05
    • Sufentanil solution for injection, Hikma, 50 mcg/mL, 5 mL ampule, 10 count, NDC 00641-6112-10
    • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 5 mL vial, 10 count, NDC 00409-3382-25
Reason for the Shortage
    • Akorn has Sufenta injection on shortage due to increased demand for the product.
    • Hikma did not provide a reason for the shortage.
    • Pfizer has sufentanil injection on shortage due to manufacturing delays.
Available Products
    • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 1 mL vial, 10 count, NDC 00409-3382-21
    • Sufentanil solution for injection, Pfizer, 50 mcg/mL, 2 mL vial, 10 count, NDC 00409-3382-22

Estimated Resupply Dates

    • Akorn has Sufenta 50 mcg/mL 1 mL, 2 mL, and 5 mL ampules on allocation.
    • Hikma has sufentanil 50 mcg/mL 5 mL ampules on back order and the company cannot estimate a release date.
    • Pfizer has sufentanil 50 mcg/mL 5 mL vials on back order and the company estimates a release date of December 2018.

Implications for Patient Care

    • ASHP has an FAQ on the injectable opioid shortage at https://www.ashp.org/Drug-Shortages/Shortage-Resources/Injectable-Opioid-Shortages-FAQ. This discusses multiple issues including inventory and pharmacy operational strategies.

Updated

Updated August 12, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 12, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide